Smoking is, by a wide margin, the single largest risk factor for small cell lung cancer (SCLC). Roughly 95 percent of people diagnosed with SCLC have a history of tobacco use, and the risk climbs steeply with the number of years and cigarettes smoked. But the story doesn’t end with cigarettes. Radon gas, certain workplace chemicals, pre-existing lung disease, family history, and even secondhand smoke all independently raise the odds, and they interact with smoking in ways that multiply danger rather than simply adding to it.
Smoking Intensity and the Dose-Response Curve
Among all lung cancer subtypes, SCLC has the tightest link to tobacco. A large pooled analysis across the International Lung Cancer Consortium found that the risk of SCLC compared to nonsmokers rose in a clear staircase pattern with cumulative smoking exposure: people who had smoked fewer than 20 pack-years had about four times the odds, while those who had smoked 80 or more pack-years faced roughly 69 times the odds.1EBioMedicine. Associated Links Among Smoking, Chronic Obstructive Pulmonary Disease, and Small Cell Lung Cancer: A Pooled Analysis in the International Lung Canada Consortium That gradient is far steeper than for most other lung cancer types. A separate study comparing SCLC and non-small-cell lung cancer (NSCLC) patients who were all smokers found that having smoked more than 40 pack-years nearly quadrupled the odds of the cancer being small cell rather than another type.2PubMed. Differences between small-cell lung cancer and non-small-cell lung cancer among tobacco smokers
What makes SCLC so tightly bound to smoking? When researchers sequenced the genome of a SCLC cell line, they identified over 22,000 mutations, many of them bearing the chemical fingerprints of specific carcinogens found in tobacco smoke. Different components of the “cocktail” in cigarettes favor different types of DNA damage, and the sheer volume of mutations helps explain why SCLC is so aggressive and fast-growing from the start.3PubMed Central. A small-cell lung cancer genome with complex signatures of tobacco exposure
Secondhand Smoke
People who have never smoked themselves but live or work around tobacco smoke also face elevated SCLC risk, and the increase is larger than for other lung cancer types. A pooled analysis of never-smokers found that those exposed to secondhand smoke had about three times the odds of developing SCLC compared to never-smokers with no secondhand exposure. For comparison, the same analysis estimated about a 26 percent increase for adenocarcinoma and a 41 percent increase for squamous cell carcinoma.4PubMed Central. Exposure to secondhand tobacco smoke and lung cancer by histological type: a pooled analysis of the International Lung Cancer Consortium (ILCCO) Those numbers make SCLC the subtype most disproportionately linked to passive smoking, even though it remains relatively rare among never-smokers overall.
Residential Radon
Radon is a colorless, odorless radioactive gas that seeps from soil and rock into buildings. It is the second-leading cause of lung cancer after smoking in most countries, and SCLC appears to be the subtype most sensitive to it. A systematic review concluded that SCLC seems to be the histological type of lung cancer most tightly related to residential radon exposure.5PubMed. Residential radon and small cell lung cancer. A systematic review A subsequent meta-analysis of case-control studies quantified the association: SCLC had roughly double the odds with radon exposure, compared to about a 58 percent increase for adenocarcinoma and a 43 percent increase for squamous cell carcinoma.6PubMed Central. Residential Radon and Histological Types of Lung Cancer: A Meta-Analysis of Case‒Control Studies
One study that specifically focused on SCLC found a clear dose-response pattern. People living in homes with radon levels above the U.S. EPA action level of 148 Bq/m³ had about twice the odds of SCLC compared to those in homes below 50 Bq/m³. Smokers exposed to higher radon concentrations had a much greater risk than smokers exposed to lower concentrations, suggesting that radon and tobacco work together in a multiplicative way.7PubMed. Residential Radon and Small Cell Lung Cancer. Final Results of the Small Cell Study Testing your home for radon and mitigating high levels is one of the few actionable steps for reducing SCLC risk beyond quitting smoking.
Occupational Exposures
Certain jobs carry an independent SCLC risk that persists even after accounting for smoking and radon. A study examining occupation as a risk factor found that workers in occupations already known to raise lung cancer risk (those involving asbestos, silica, diesel exhaust, welding fumes, and similar exposures) had about twice the odds of SCLC compared to workers in lower-risk occupations. Among workers who were also moderate-to-heavy smokers, that combined risk jumped to roughly 12 times the odds of those who neither smoked heavily nor worked in those occupations.8PubMed Central. Occupation as a risk factor of small cell lung cancer
Some chemical exposures have an especially strong link to SCLC specifically. Workers exposed to chloromethyl ethers, chemicals once widely used in the production of ion-exchange resins and other industrial processes, developed lung cancer at rates five to nearly eight times higher than unexposed coworkers or the general population. The cancers in exposed workers were predominantly the small-cell type, and they tended to occur at younger ages.9American Journal of Epidemiology. Incidence of Respiratory Cancer among Workers Exposed to Chloromethyl-ethers While chloromethyl ether use has been curtailed in many countries, the finding illustrates a broader point: heavy exposure to certain occupational carcinogens can steer the type of lung cancer that develops toward small cell.
Pre-existing Lung Disease
Chronic obstructive pulmonary disease (COPD) and emphysema are independent risk factors for SCLC. The International Lung Cancer Consortium pooled analysis found that having COPD was associated with nearly double the odds of SCLC, even after adjusting for age, sex, and the number of pack-years smoked.10EBioMedicine. Cigarette Smoking, Chronic Obstructive Pulmonary Disease, and Small Cell Lung Cancer Risk: A Pooled Analysis That finding matters because COPD and smoking are deeply intertwined: smoking causes COPD, and COPD in turn appears to create a lung environment that further promotes cancer development. The researchers described COPD as partially mediating the path from smoking to SCLC, meaning that some of smoking’s cancer-promoting effect works through the chronic inflammation and tissue damage that defines COPD.
Emphysema shows a particularly strong connection. A study using CT scans to assess emphysema in smokers found that the presence of emphysema raised the risk of all major lung cancer types, but the effect was strongest for SCLC, with more than five times the odds compared to smokers without emphysema.11Cancer Prevention Research. Effect of Emphysema on Lung Cancer Risk in Smokers: A Computed Tomography–Based Assessment For smokers, this means that already having visible lung damage on a CT scan is not just a quality-of-life concern; it substantially increases the probability that any future lung cancer will be the aggressive small cell variety.
Genetic Susceptibility and Family History
While SCLC is overwhelmingly driven by environmental exposures, genetic background plays a role in who develops it. Variants in genes encoding nicotine acetylcholine receptor subunits have been linked to lung cancer risk across populations. A Japanese case-control study found that a specific haplotype in this gene region was associated with more than double the odds of lung cancer, and the association held across all histological types including SCLC. Importantly, the link persisted in both smokers and nonsmokers, suggesting that these gene variants raise cancer susceptibility independently of their potential effect on smoking behavior.12Carcinogenesis. Contribution of nicotine acetylcholine receptor polymorphisms to lung cancer risk in a smoking-independent manner in the Japanese
Family history also appears to matter. A study of Japanese men and women found that having a sibling with lung cancer was associated with more than double the odds of developing small cell carcinoma.13The Tohoku Journal of Experimental Medicine. Association between Family History of Cancer and Lung Cancer Risk among Japanese Men and Women These genetic and familial findings don’t change the practical advice for most people, since quitting smoking and reducing radon exposure remain the dominant levers you can pull. But they help explain why some heavy smokers never develop SCLC while, rarely, a lifelong nonsmoker does.
Sex, Age, and Shifting Demographics
SCLC has historically been far more common in men, mainly because men smoked at higher rates. But the gap has narrowed dramatically. In the United States, the proportion of women among SCLC patients rose from about 31 percent to over 51 percent in recent decades, and the median age at diagnosis climbed from 63 to 69 years.14PubMed. The changing landscape of small cell lung cancer Among younger adults (under 55), women now actually have higher SCLC incidence rates than men in most racial groups and geographic regions across the U.S.15Scientific Reports. Gender disparities in lung cancer incidence in the United States during 2001–2019
Part of this shift reflects historical smoking patterns: women took up smoking in large numbers later than men, so the peak of smoking-related SCLC in women has arrived later. But research has also suggested that women may be more susceptible to SCLC at equivalent levels of tobacco exposure. SCLC incidence increased more rapidly in women than in men, and faster than for other cell types.16PubMed. Small cell lung cancer in women: risk associated with smoking, prior respiratory disease, and occupation
The age shift is also striking. A SEER database analysis showed that the proportion of elderly patients among all SCLC cases doubled from 23 percent in 1975 to 44 percent by 2010, and within that elderly group, the share of women rose from 25 percent to 49 percent.17PubMed. Changing epidemiology of elderly small cell lung cancer patients over the last 40 years; a SEER database analysis SCLC is increasingly a disease of older adults, though it can and does occur in younger people, especially heavy smokers.
Quitting Smoking and How Quickly Risk Falls
The good news is that SCLC risk drops substantially after quitting smoking, and the decline is actually steeper than for most other lung cancer subtypes. One large study found that the greatest risk reduction after smoking cessation was seen in SCLC and squamous cell carcinoma, with smaller reductions for adenocarcinoma and large cell cancer.18PubMed. Effect of smoking cessation on major histologic types of lung cancer The bad news is that the risk never fully returns to baseline. Even 20 years after quitting, former smokers still face roughly three to four times the risk of SCLC compared to people who never smoked.19EBioMedicine. Cigarette Smoking, Chronic Obstructive Pulmonary Disease, and Small Cell Lung Cancer Risk: A Pooled Analysis The explanation may be that tobacco smoke causes some irreversible DNA and tissue damage in the lungs. Even so, earlier quitting is always better: the sooner you stop, the steeper the drop in risk, and two decades of declining risk is far preferable to continued smoking.
Vaping Combined with Smoking
E-cigarettes are too new for researchers to have long-term data on SCLC risk from vaping alone. But early data on the combination of vaping and smoking is concerning. An analysis that compared lung cancer risk across vaping and smoking categories found that people who both vaped and smoked cigarettes had roughly three to four times the lung cancer risk of those who only smoked, regardless of cell type. While the small cell and large cell estimates in that study were based on smaller samples, they tracked similarly to the elevated risk seen for squamous cell carcinoma.20PubMed Central. Vaping, Smoking and Lung Cancer Risk The finding doesn’t tell us whether vaping alone raises SCLC risk, but it does suggest that using e-cigarettes on top of continued smoking is not a harmless compromise.
When Non-Small-Cell Lung Cancer Transforms into SCLC
There is one route to SCLC that has nothing to do with the usual risk factors. Some patients initially diagnosed with a certain type of NSCLC, specifically those whose tumors carry an EGFR mutation, develop resistance to targeted therapy when their cancer transforms into small cell biology. Estimates of how often this happens vary: one study put it at about 3 to 10 percent of EGFR-mutant NSCLCs, with a median time to transformation of roughly 18 months after starting treatment.21PubMed Central. EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes A more recent review suggested the proportion could be as high as 14 percent of resistance cases involving histological transformation.22PubMed Central. Small Cell Transformation of EGFR-Mutant NSCLC Treated with Tyrosine Kinase Inhibition
Research into the molecular basis of this transformation found that loss of the Retinoblastoma (RB) tumor suppressor gene occurred in all cases of SCLC transformation but was rare in cancers that remained NSCLC. The transformed tumors also took on many of the hallmarks of classical SCLC, including increased expression of neuroendocrine markers and greater sensitivity to certain drugs targeting the BCL2 protein family.23Nature Communications. RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer This pathway is a reminder that SCLC can arise even in patients who have never smoked and whose original cancer was a different subtype entirely.
Socioeconomic Factors and Disparities in Outcomes
SCLC doesn’t distribute itself evenly across income levels or communities. SCLC incidence tends to be highest in low- and medium-poverty areas, likely reflecting higher smoking rates and greater exposure to occupational and environmental carcinogens in those populations.24Scientific Reports. Survival changes in patients with small cell lung cancer and disparities between different sexes, socioeconomic statuses and ages There is also evidence that socioeconomic factors shape survival after diagnosis. A large SEER-based study of limited-stage SCLC found that higher income, higher education, and having private insurance were all associated with longer survival, even after adjusting for treatment characteristics.25JAMA Network Open. Association of Race, Socioeconomic Factors, and Treatment Characteristics With Overall Survival in Patients With Limited-Stage Small Cell Lung Cancer
These gaps have been narrowing over time as standard chemotherapy regimens and radiotherapy became more widely available, but they haven’t disappeared. For a disease where early and aggressive treatment is critical, any delay or barrier to care matters. The same JAMA analysis found that female sex and earlier stage at diagnosis were independently linked to better survival, reinforcing the value of catching the disease sooner rather than later, something more accessible to patients with better healthcare coverage.
Air Pollution and Ionizing Radiation Beyond Radon
Fine particulate air pollution (PM2.5) is an established lung carcinogen, and while most evidence groups all lung cancer types together, the mechanism overlaps substantially with the pathways relevant to SCLC. A study of a low-smoking cohort found that every 10 µg/m³ increase in PM2.5 was associated with about a 43 percent increase in overall lung cancer incidence. Among people who spent more than an hour a day outdoors, the increase was closer to 68 percent.26Environmental Health Perspectives. The Association between Ambient Fine Particulate Air Pollution and Lung Cancer Incidence: Results from the AHSMOG-2 Study That study did not break out results by histological type, but because it was conducted in a population with very low smoking rates, it suggests that chronic exposure to polluted air can contribute to lung cancer risk even in the absence of tobacco.
Ionizing radiation from sources other than radon has also been studied. Analysis of lung cancer among Japanese atomic bomb survivors found that small cell carcinoma showed somewhat greater sensitivity to radiation than adenocarcinoma or squamous cell carcinoma, though the differences between types did not reach statistical significance.27Journal of Radiation Research. Lung Cancer Incidence among Japanese A-Bomb Survivors, 1950-80 This is consistent with the broader pattern: the cells that give rise to SCLC seem especially vulnerable to DNA-damaging agents, whether those agents are chemicals in tobacco smoke, alpha particles from radon, or gamma radiation from a nuclear detonation.